The facility complex is scheduled to become operational in the first six months of 2021. Polyamide 12 is in demand in attractive growth markets such as the automotive industry, oil and gas pipelines, and 3D printing.
The €400 million project, Evonik’s largest investment in Germany so far, is expected to increase the Group’s overall capacity for PA12 by more than 50%. Additional facilities for producing the polymer and its precursors will be constructed at the Marl Chemical Park in North Rhine-Westphalia and will supplement the existing PA12 production plant.
“This project is a special challenge,” said Dr. Ralf Düssel, head of the High Performance Polymers Business Line at Evonik, which, among other products, manufactures VESTAMID and VESTOSINT, the Group’s PA12 granules and powders. “The construction project is located in the direct vicinity of ongoing production, with special safety standards, and we have to keep areas for construction containers, material storage, and pre-assembly open in addition to the actual construction sites. The Marl Chemical Park offers us optimal conditions for this extraordinary feat. Once we start up the new facility, the existing structures that have been in place for over 50 years will be used for product distribution.”